The novel approach of tirzepatide peptide represents a major development in the care of type 2 diabetes. Unlike existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP – resulting https://tirzepatide-peptide185727.timeblog.net/77924822/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment